Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR-JIA
ISRCTN54174557Phase 4Recruiting
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of methylprednisolone, prednisolone and methotrexate in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Alder Hey Children's NHS Foundation Trust. Primary endpoints: JADAS10 disease activity at 6 weeks, Incremental cost per quality-adjusted life year gained and 1 more. Started Mar 2024; status: recruiting.
02
Drugs
methylprednisoloneprednisolonemethotrexate
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on ISRCTN54174557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54174557.